Latest Breaking News On - Professor xiaodong guan - Page 1 : comparemela.com

<p>More than one-eighth of the randomized trials of cancer drugs seeking regulatory approval in China in recent years used inappropriate controls to test the effectiveness and safety of the drugs, according to a new study published December 12^th<strong> </strong>in the open access journal <em>PLOS Medicine </em>by Professor Xiaodong Guan of Peking University, China, and colleagues.</p>

United statesXiaodong guanUniversity health science centerResearch on equitable accessNational natural science foundation of chinaOriented oncology drug researchMethod of researchProfessor xiaodong guanPeking universityClinical value oriented oncology drug researchNational natural science foundationEquitable accessRational usePeking university health science